Collectively, these results suggest that AKT1 has an inhibitory activity on migration and invasion of NSCLC cells with KRAS or EGFR mutations, underscoring genetic contribution to the apparent paradoxical roles of AKT1 in these cellular processes. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.